Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 756

1.

Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease.

Jaiswal S, Libby P.

Nat Rev Cardiol. 2019 Aug 12. doi: 10.1038/s41569-019-0247-5. [Epub ahead of print] Review.

PMID:
31406340
2.

Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key?

Fruchart JC, Santos RD, Yamashita S, Libby P; International Atherosclerosis Society/R3i Foundation Consensus Panel.

Diabetes Metab Syndr. 2019 Jul - Aug;13(4):2723-2725. doi: 10.1016/j.dsx.2019.05.034. Epub 2019 May 30. Review. No abstract available.

PMID:
31405699
3.

Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical Outcomes.

Buckley LF, Libby P.

J Cardiovasc Pharmacol. 2019 Jul 22. doi: 10.1097/FJC.0000000000000701. [Epub ahead of print]

PMID:
31356538
4.

Clonal Hematopoiesis: Crossroads of Aging, Cardiovascular Disease, and Cancer: JACC Review Topic of the Week.

Libby P, Sidlow R, Lin AE, Gupta D, Jones LW, Moslehi J, Zeiher A, Jaiswal S, Schulz C, Blankstein R, Bolton KL, Steensma D, Levine RL, Ebert BL.

J Am Coll Cardiol. 2019 Jul 30;74(4):567-577. doi: 10.1016/j.jacc.2019.06.007. Review.

PMID:
31345432
5.

Anticytokine Immune Therapy and Atherothrombotic Cardiovascular Risk.

Ait-Oufella H, Libby P, Tedgui A.

Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1510-1519. doi: 10.1161/ATVBAHA.119.311998. Epub 2019 Jul 11.

PMID:
31294625
6.

Low-Density Lipoprotein Cholesterol After an Acute Coronary Syndrome: How Low to Go?

Qamar A, Libby P.

Curr Cardiol Rep. 2019 Jun 27;21(8):77. doi: 10.1007/s11886-019-1160-6. Review.

PMID:
31250329
7.

Immunometabolism and atherosclerosis: perspectives and clinical significance: a position paper from the Working Group on Atherosclerosis and Vascular Biology of the European Society of Cardiology.

Ketelhuth DFJ, Lutgens E, Bäck M, Binder CJ, Van den Bossche J, Daniel C, Dumitriu IE, Hoefer I, Libby P, O'Neill L, Weber C, Evans PC.

Cardiovasc Res. 2019 Jul 1;115(9):1385-1392. doi: 10.1093/cvr/cvz166.

PMID:
31228191
8.

The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.

Fruchart JC, Santos RD, Aguilar-Salinas C, Aikawa M, Al Rasadi K, Amarenco P, Barter PJ, Ceska R, Corsini A, Després JP, Duriez P, Eckel RH, Ezhov MV, Farnier M, Ginsberg HN, Hermans MP, Ishibashi S, Karpe F, Kodama T, Koenig W, Krempf M, Lim S, Lorenzatti AJ, McPherson R, Nuñez-Cortes JM, Nordestgaard BG, Ogawa H, Packard CJ, Plutzky J, Ponte-Negretti CI, Pradhan A, Ray KK, Reiner Ž, Ridker PM, Ruscica M, Sadikot S, Shimano H, Sritara P, Stock JK, Su TC, Susekov AV, Tartar A, Taskinen MR, Tenenbaum A, Tokgözoğlu LS, Tomlinson B, Tybjærg-Hansen A, Valensi P, Vrablík M, Wahli W, Watts GF, Yamashita S, Yokote K, Zambon A, Libby P.

Cardiovasc Diabetol. 2019 Jun 4;18(1):71. doi: 10.1186/s12933-019-0864-7. Review.

9.

c-Myb Exacerbates Atherosclerosis through Regulation of Protective IgM-Producing Antibody-Secreting Cells.

Shikatani EA, Besla R, Ensan S, Upadhye A, Khyzha N, Li A, Emoto T, Chiu F, Degousee N, Moreau JM, Perry HM, Thayaparan D, Cheng HS, Pacheco S, Smyth D, Noyan H, Zavitz CCJ, Bauer CMT, Hilgendorf I, Libby P, Swirski FK, Gommerman JL, Fish JE, Stampfli MR, Cybulsky MI, Rubin BB, Paige CJ, Bender TP, McNamara CA, Husain M, Robbins CS.

Cell Rep. 2019 May 21;27(8):2304-2312.e6. doi: 10.1016/j.celrep.2019.04.090.

10.

Targeting RNA to lower triglycerides: long strides from short molecules.

Qamar A, Libby P, Bhatt DL.

Eur Heart J. 2019 May 15. pii: ehz321. doi: 10.1093/eurheartj/ehz321. [Epub ahead of print] No abstract available.

PMID:
31089714
11.

Leaders in Cardiovascular Research: Peter Libby.

Guzik TJ, Libby P.

Cardiovasc Res. 2019 May 1;115(6):e61-e62. doi: 10.1093/cvr/cvz069. No abstract available.

PMID:
31077586
12.

Johann Sebastian Bach.

Libby P.

Circ Res. 2019 Apr 26;124(9):1303-1308. doi: 10.1161/CIRCRESAHA.119.315025. No abstract available.

PMID:
31021721
13.

Dietary cholesterol is essential to mast cell activation and associated obesity and diabetes in mice.

Zhang X, Huang Q, Wang X, Deng Z, Li J, Yan X, Jauhiainen M, Metso J, Libby P, Liu J, Shi GP.

Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1690-1700. doi: 10.1016/j.bbadis.2019.04.006. Epub 2019 Apr 9.

PMID:
30978390
14.

Modulating Adaptive Immunity in Vascular Disease: CD4 to the Fore.

Libby P, Lichtman AI.

J Am Coll Cardiol. 2019 Apr 16;73(14):1824-1826. doi: 10.1016/j.jacc.2019.01.050. No abstract available.

PMID:
30975300
15.

Arson in the artery: Who set the atheroma aflame?

Libby P.

Trends Cardiovasc Med. 2019 Mar 28. pii: S1050-1738(19)30043-X. doi: 10.1016/j.tcm.2019.03.006. [Epub ahead of print]

PMID:
30956033
16.

Arterial Inflammation: The Heat Before the Storm.

Blankstein R, Libby P, Bhatt DL.

J Am Coll Cardiol. 2019 Apr 2;73(12):1383-1385. doi: 10.1016/j.jacc.2019.02.002. No abstract available.

PMID:
30922469
17.

Inflammation: a common contributor to cancer, aging, and cardiovascular diseases-expanding the concept of cardio-oncology.

Libby P, Kobold S.

Cardiovasc Res. 2019 Apr 15;115(5):824-829. doi: 10.1093/cvr/cvz058.

PMID:
30830168
18.

Novel Antiatherosclerotic Therapies.

Libby P, Everett BM.

Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):538-545. doi: 10.1161/ATVBAHA.118.310958.

PMID:
30816799
19.

Once more unto the breach: endothelial permeability and atherogenesis.

Libby P.

Eur Heart J. 2019 Mar 14;40(11):938-940. doi: 10.1093/eurheartj/ehz081.

PMID:
30805590
20.

Dysregulation of IL-33/ST2 signaling and myocardial periarteriolar fibrosis.

Garbern JC, Williams J, Kristl AC, Malick A, Rachmin I, Gaeta B, Ahmed N, Vujic A, Libby P, Lee RT.

J Mol Cell Cardiol. 2019 Mar;128:179-186. doi: 10.1016/j.yjmcc.2019.01.018. Epub 2019 Feb 11.

PMID:
30763587
21.

Sleep modulates haematopoiesis and protects against atherosclerosis.

McAlpine CS, Kiss MG, Rattik S, He S, Vassalli A, Valet C, Anzai A, Chan CT, Mindur JE, Kahles F, Poller WC, Frodermann V, Fenn AM, Gregory AF, Halle L, Iwamoto Y, Hoyer FF, Binder CJ, Libby P, Tafti M, Scammell TE, Nahrendorf M, Swirski FK.

Nature. 2019 Feb;566(7744):383-387. doi: 10.1038/s41586-019-0948-2. Epub 2019 Feb 13.

22.

Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease.

He S, Kahles F, Rattik S, Nairz M, McAlpine CS, Anzai A, Selgrade D, Fenn AM, Chan CT, Mindur JE, Valet C, Poller WC, Halle L, Rotllan N, Iwamoto Y, Wojtkiewicz GR, Weissleder R, Libby P, Fernández-Hernando C, Drucker DJ, Nahrendorf M, Swirski FK.

Nature. 2019 Feb;566(7742):115-119. doi: 10.1038/s41586-018-0849-9. Epub 2019 Jan 30.

23.

Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis.

Vromman A, Ruvkun V, Shvartz E, Wojtkiewicz G, Santos Masson G, Tesmenitsky Y, Folco E, Gram H, Nahrendorf M, Swirski FK, Sukhova GK, Libby P.

Eur Heart J. 2019 Aug 7;40(30):2482-2491. doi: 10.1093/eurheartj/ehz008.

PMID:
30698710
24.

Self-reactive CD4+ IL-3+ T cells amplify autoimmune inflammation in myocarditis by inciting monocyte chemotaxis.

Anzai A, Mindur JE, Halle L, Sano S, Choi JL, He S, McAlpine CS, Chan CT, Kahles F, Valet C, Fenn AM, Nairz M, Rattik S, Iwamoto Y, Fairweather D, Walsh K, Libby P, Nahrendorf M, Swirski FK.

J Exp Med. 2019 Feb 4;216(2):369-383. doi: 10.1084/jem.20180722. Epub 2019 Jan 22.

25.

Deficiency of mouse mast cell protease 4 mitigates cardiac dysfunctions in mice after myocardium infarction.

Wang Y, Liu CL, Fang W, Zhang X, Yang C, Li J, Liu J, Sukhova GK, Gurish MF, Libby P, Shi GP, Zhang J.

Biochim Biophys Acta Mol Basis Dis. 2019 Jun 1;1865(6):1170-1181. doi: 10.1016/j.bbadis.2019.01.011. Epub 2019 Jan 11.

PMID:
30639224
26.

Cardiovascular Benefits of GLP-1 Receptor Agonism: Is Inflammation a Key?

Marx N, Libby P.

JACC Basic Transl Sci. 2018 Dec 31;3(6):858-860. doi: 10.1016/j.jacbts.2018.11.008. eCollection 2018 Dec. No abstract available.

27.

Nanoparticles targeting extra domain B of fibronectin-specific to the atherosclerotic lesion types III, IV, and V-enhance plaque detection and cargo delivery.

Yu M, Ortega CA, Si K, Molinaro R, Schoen FJ, Leitao RFC, Xu X, Mahmoudi M, Ahn S, Liu J, Saw PE, Lee IH, Brayner MMB, Lotfi A, Shi J, Libby P, Jon S, Farokhzad OC.

Theranostics. 2018 Nov 15;8(21):6008-6024. doi: 10.7150/thno.24365. eCollection 2018.

28.

Reassessing the Mechanisms of Acute Coronary Syndromes.

Libby P, Pasterkamp G, Crea F, Jang IK.

Circ Res. 2019 Jan 4;124(1):150-160. doi: 10.1161/CIRCRESAHA.118.311098.

PMID:
30605419
29.

Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure.

Everett BM, Cornel JH, Lainscak M, Anker SD, Abbate A, Thuren T, Libby P, Glynn RJ, Ridker PM.

Circulation. 2019 Mar 5;139(10):1289-1299. doi: 10.1161/CIRCULATIONAHA.118.038010.

PMID:
30586730
30.

Jak-ing Up the Plaque's Lipid Core…and Even More.

Libby P, Molinaro R, Sellar RS, Ebert BL.

Circ Res. 2018 Nov 9;123(11):1180-1182. doi: 10.1161/CIRCRESAHA.118.314074. No abstract available.

PMID:
30571474
31.

Fish Oil and Perioperative Bleeding.

Akintoye E, Sethi P, Harris WS, Thompson PA, Marchioli R, Tavazzi L, Latini R, Pretorius M, Brown NJ, Libby P, Mozaffarian D.

Circ Cardiovasc Qual Outcomes. 2018 Nov;11(11):e004584. doi: 10.1161/CIRCOUTCOMES.118.004584.

PMID:
30571332
32.

CHIPping Away at the Pathogenesis of Heart Failure.

Libby P, Jaiswal S, Lin AE, Ebert BL.

JAMA Cardiol. 2019 Jan 1;4(1):5-6. doi: 10.1001/jamacardio.2018.4039. No abstract available.

PMID:
30566187
33.

Medical Therapy for Long-Term Prevention of Atherothrombosis Following an Acute Coronary Syndrome: JACC State-of-the-Art Review.

Gallone G, Baldetti L, Pagnesi M, Latib A, Colombo A, Libby P, Giannini F.

J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2886-2903. doi: 10.1016/j.jacc.2018.09.052. Review.

PMID:
30522652
34.

Cathepsin K-deficiency impairs mouse cardiac function after myocardial infarction.

Fang W, He A, Xiang MX, Lin Y, Wang Y, Li J, Yang C, Zhang X, Liu CL, Sukhova GK, Barascuk N, Larsen L, Karsdal M, Libby P, Shi GP.

J Mol Cell Cardiol. 2019 Feb;127:44-56. doi: 10.1016/j.yjmcc.2018.11.010. Epub 2018 Nov 19.

PMID:
30465799
35.

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.

Ridker PM, Everett BM, Pradhan A, MacFadyen JG, Solomon DH, Zaharris E, Mam V, Hasan A, Rosenberg Y, Iturriaga E, Gupta M, Tsigoulis M, Verma S, Clearfield M, Libby P, Goldhaber SZ, Seagle R, Ofori C, Saklayen M, Butman S, Singh N, Le May M, Bertrand O, Johnston J, Paynter NP, Glynn RJ; CIRT Investigators.

N Engl J Med. 2019 Feb 21;380(8):752-762. doi: 10.1056/NEJMoa1809798. Epub 2018 Nov 10.

PMID:
30415610
36.

IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- mice.

Wang J, Cheng X, Xiang MX, Alanne-Kinnunen M, Wang JA, Chen H, He A, Sun X, Lin Y, Tang TT, Tu X, Sjöberg S, Sukhova GK, Liao YH, Conrad DH, Yu L, Kawakami T, Kovanen PT, Libby P, Shi GP.

J Clin Invest. 2018 Nov 1;128(11):5184. doi: 10.1172/JCI124107. Epub 2018 Nov 1. No abstract available.

37.

CHIP (Clonal Hematopoiesis of Indeterminate Potential).

Libby P, Ebert BL.

Circulation. 2018 Aug 14;138(7):666-668. doi: 10.1161/CIRCULATIONAHA.118.034392. No abstract available.

38.

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study.

Pradhan AD, Paynter NP, Everett BM, Glynn RJ, Amarenco P, Elam M, Ginsberg H, Hiatt WR, Ishibashi S, Koenig W, Nordestgaard BG, Fruchart JC, Libby P, Ridker PM.

Am Heart J. 2018 Dec;206:80-93. doi: 10.1016/j.ahj.2018.09.011. Epub 2018 Sep 29. Review.

39.

Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week.

Libby P, Loscalzo J, Ridker PM, Farkouh ME, Hsue PY, Fuster V, Hasan AA, Amar S.

J Am Coll Cardiol. 2018 Oct 23;72(17):2071-2081. doi: 10.1016/j.jacc.2018.08.1043. Review.

PMID:
30336831
40.

Relationship of Interleukin-1β Blockade With Incident Gout and Serum Uric Acid Levels: Exploratory Analysis of a Randomized Controlled Trial.

Solomon DH, Glynn RJ, MacFadyen JG, Libby P, Thuren T, Everett BM, Ridker PM.

Ann Intern Med. 2018 Oct 16;169(8):535-542. doi: 10.7326/M18-1167. Epub 2018 Sep 18.

PMID:
30242335
41.

Internal Bleeding: Is Intraplaque Hemorrhage a Decoration or a Driver?

Michel JB, Libby P, Franck G.

JACC Basic Transl Sci. 2018 Aug 28;3(4):481-484. doi: 10.1016/j.jacbts.2018.04.002. eCollection 2018 Aug. No abstract available.

42.

Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS).

Ridker PM, Libby P, MacFadyen JG, Thuren T, Ballantyne C, Fonseca F, Koenig W, Shimokawa H, Everett BM, Glynn RJ.

Eur Heart J. 2018 Oct 7;39(38):3499-3507. doi: 10.1093/eurheartj/ehy310.

PMID:
30165610
43.

Partnerships Promote Translation in Biomedicine.

Libby P.

JACC Basic Transl Sci. 2018 Jun 25;3(3):431-433. doi: 10.1016/j.jacbts.2018.05.001. eCollection 2018 Jun. No abstract available.

44.

Neutrophil Extracellular Traps Induce Endothelial Cell Activation and Tissue Factor Production Through Interleukin-1α and Cathepsin G.

Folco EJ, Mawson TL, Vromman A, Bernardes-Souza B, Franck G, Persson O, Nakamura M, Newton G, Luscinskas FW, Libby P.

Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1901-1912. doi: 10.1161/ATVBAHA.118.311150.

45.

Biologically-Based Therapies for Aortic Diseases: Why the Long Lag in Translation?

Libby P.

J Am Coll Cardiol. 2018 Jul 3;72(1):58-61. doi: 10.1016/j.jacc.2018.05.005. No abstract available.

46.

Atherosclerosis and inflammation: overview and updates.

Geovanini GR, Libby P.

Clin Sci (Lond). 2018 Jun 21;132(12):1243-1252. doi: 10.1042/CS20180306. Print 2018 Jun 29. Review.

PMID:
29930142
47.

Clonal Hematopoiesis Confers Predisposition to Both Cardiovascular Disease and Cancer: A Newly Recognized Link Between Two Major Killers.

Ebert BL, Libby P.

Ann Intern Med. 2018 Jul 17;169(2):116-117. doi: 10.7326/M18-0737. Epub 2018 May 29. No abstract available.

PMID:
29809241
48.

Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease.

Ridker PM, MacFadyen JG, Glynn RJ, Koenig W, Libby P, Everett BM, Lefkowitz M, Thuren T, Cornel JH.

J Am Coll Cardiol. 2018 May 29;71(21):2405-2414. doi: 10.1016/j.jacc.2018.03.490.

49.

Association between Obstructive Sleep Apnea and Cardiovascular Risk Factors: Variation by Age, Sex, and Race. The Multi-Ethnic Study of Atherosclerosis.

Geovanini GR, Wang R, Weng J, Jenny NS, Shea S, Allison M, Libby P, Redline S.

Ann Am Thorac Soc. 2018 Aug;15(8):970-977. doi: 10.1513/AnnalsATS.201802-121OC.

50.

The potential benefits of aspirin for primary cardiovascular prevention in rheumatoid arthritis: a secondary analysis of the PRECISION Trial.

Solomon DH, Libby P, Yeomans ND, Wang Q, Wolski KE, Nissen SE, Husni ME.

Rheumatology (Oxford). 2018 Aug 1;57(8):1364-1369. doi: 10.1093/rheumatology/key105.

PMID:
29688503

Supplemental Content

Support Center